Nurse Anesthetist - CR in Washington, MO Accepting Medicare

8 Nurse Anesthetist - CR nurses found. Showing 1 - 8

Marilou Grainger, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8000

Mrs. Katie Marie Frillman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8301

Terri L. Morgan, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8090

Virgina Lee Painter, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8090

Virginia R Hall, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-290-8090

Joseph W Hassler, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8000

Timothy L Piontek, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8090

Leslie Corinn Jacobs, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8090    Fax: 636-390-7385

News Archive

Ruthigen treats first human subjects with leading drug candidate RUT58-60

Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.

Donepezil slows brain shrinkage in some patients with mild cognitive impairment

According to a new study, the drug donepezil measurably slows the rate of brain shrinkage in some patients with mild cognitive impairment, a pre-Alzheimer's disease condition. The shrinkage was measured by magnetic resonance imaging (MRI).

New compound offers longer lasting painkilling effects

Medications have long been used to treat pain caused by injury or chronic conditions. Unfortunately, most are short-term fixes or cause side effects that limit their use. Researchers at the University of Missouri have discovered a new compound that offers longer lasting painkilling effects, and shows promise as an alternative to current anesthetics.

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

Removing tumor's protective wall could help boost the effects of cancer treatments

Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).

Read more Medical News

› Verified 2 days ago